Drug
Ganciclovir clinical trials
Also written Zirgan and Cytovene.
- studies test it
- 74
- open now
- 3
- in phase 3
- 13
- first study started
- 1990
Keep track of what changes. Save the Ganciclovir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
41 studies that test it; most in 2000 (4)
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1991 | 1 |
| 1992 | 1 |
| 1994 | 1 |
| 1997 | 2 |
| 1999 | 1 |
| 2000 | 4 |
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 16
- Phase 2
- 13
- Phase 3
- 13
- Phase 4
- 8
- No phase
- 25
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 19 · Other 55
National Institute of Allergy and Infectious Diseases (NIAID) (17) · Hoffmann-La Roche (13) · Roche Global Development (3) · Fred Hutchinson Cancer Center (2) · City of Hope Medical Center (2) · National Center for Research Resources (NCRR) (2) · University of California, San Francisco (2) · Al-Azhar University (1)
Often tested with
Tested in the same studies.
Valganciclovir (10) · Foscarnet (5) · Acyclovir (3) · Sirolimus (2) · Daclizumab (2) · Zidovudine (2) · Arginine butyrate (2) · Tacrolimus (1)
Studies
Open first, then newest update. How each study uses Ganciclovir is read from its arms, and is right about nine times in ten.
Testing it · 74
- Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and IINot yet recruitingPhase 2University of California, San FranciscoNCT07513623Written as Ganciclovir (GCV)
- Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic RhinitisRecruitingNot applicableUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNCT06436534Written as Ganciclovir Oral Capsule
- Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus RetinitisRecruitingEarly Phase 1Tianjin Medical UniversityNCT05911503Written as 2% Ganciclovir Eye Drops
- Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and SepsisTerminatedPhase 3Fred Hutchinson Cancer CenterNCT04706507Written as IV Ganciclovir
- Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment OutcomesTerminatedPhase 2/3University of California, San FranciscoNCT03586284Written as Ganciclovir Sodium
- Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic KeratitisCompletedNot applicableAl-Azhar UniversityNCT06757907Written as Ganciclovir (GCV)
- Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene CopolymerplasmidCompletedPhase 1Gene Surgery LLCNCT05578820Written as Ganciclovir
- Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.CompletedPhase 3Maimónides Biomedical Research Institute of CórdobaNCT03699254Written as Ganciclovir
- CMV-CTL for the Treatment of CMV Infection After HSCTCompletedPhase 4Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineNCT03004261Written as Ganciclovir
- PTH - Preemptive Treatment for HerpesviridaeCompletedPhase 4Assistance Publique Hopitaux De MarseilleNCT02152358Written as Ganciclovir
- A Study of Ganciclovir in the Treatment of Cytomegalovirus of the EyesCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00001062Written as Ganciclovir
- The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDSCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000989Written as Ganciclovir
- A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS PatientsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000768Written as Ganciclovir
- The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIVCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001034Written as Ganciclovir
- A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) InfectionCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000995Written as Ganciclovir
- A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With GanciclovirCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000970Written as Ganciclovir
- A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral GanciclovirCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000668Written as Ganciclovir
- A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus DiseaseCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000805Written as Ganciclovir
- A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.WithdrawnPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000856Written as Ganciclovir
- A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic TherapyCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000673Written as Ganciclovir
See all 74 studies that test Ganciclovir →
Given in every arm · 6 — Ganciclovir is usual care beside what is tested
- Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant RecipientsRecruitingPhase 4University Health Network, TorontoNCT07235683Written as Valganciclovir/Ganciclovir
- Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV ViremiaNot yet recruitingPhase 2Peking University People's HospitalNCT06971913Written as Ganciclovir (GCV)
- Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver TransplantationTerminatedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02188719Written as Anti-Infective Prophylaxis
- Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex KeratitisStatus unknownNot applicableChunxiao WangNCT03217474Written as Ganciclovir (GCV)
- Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) TransplantationCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00141037Written as Ganciclovir
- Valganciclovir in Congenital CMV InfantsCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00031434Written as Ganciclovir
As the comparator · 6 — what is tested is compared with Ganciclovir
- Study Evaluating the Efficacy and Safety of ArtesunateRecruitingPhase 2Amivas Inc.NCT06853184Written as Ganciclovir (GCV)
- Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus InfectionNot yet recruitingPhase 3Hospital do Rim e HipertensãoNCT06341686Written as Ganciclovir
- Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or CidofovirCompletedPhase 3ShireNCT02931539Written as Ganciclovir
- Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant RecipientsCompletedPhase 3ShireNCT00497796Written as ganciclovir
- A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal TransplantationCompletedPhase 3Hoffmann-La RocheNCT00372229Written as Ganciclovir
- Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)CompletedPhase 3Johns Hopkins Bloomberg School of Public HealthNCT00000134Written as Ganciclovir
Codes
What other systems call Ganciclovir · ClinicalTrials.gg INT008500
- MeSH (NLM) D015774GanciclovirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) P9G3CKZ4P5GANCICLOVIRConfirmed FDA, NLM, Wikidata
- RxNorm 4678Confirmed FDA, Wikidata
- Wikidata Q417640ganciclovirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C517GanciclovirOne source FDA
- DrugBank DB01004One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015774 | Ganciclovir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | P9G3CKZ4P5 | GANCICLOVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4678 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417640 | ganciclovir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C517 | Ganciclovir | One source FDA |
| DrugBank | DB01004 | — | One source Wikidata |
Also registered as ganciclovir sodium (UNII 02L083W284 · RxNorm 82131).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.